G. Le Garff

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study

Alice Tison, Gilles Quéré, L. Misery et al. · Arthritis & Rheumatology · 2019 · 312 citations · Full text

Life Sciences, Immunology, Oncology +16

Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial

Nathalie Baize, I. Monnet, Laurent Greillier et al. · The Lancet Oncology · 2020 · 153 citations

Medicine, Oncology, Pharmacology +13

Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab

G. Le Garff, Assia Samri, Sidonie Lambert-Niclot et al. · AIDS · 2017 · 79 citations

Life Sciences, Immunology, Oncology +17

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

D. Debieuvre, Olivier Molinier, L. Falchero et al. · The Lancet Regional Health - Europe · 2022 · 76 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E-Mutant NSCLC in Real-World Setting: GFPC 01-2019

J.B. Auliac, S. Bayle, Pascal Dô et al. · Cancers · 2020 · 26 citations · Full text

Medicine, Oncology, Pharmacotherapy +14